Bethany Swencki-Underwood

Title: The Innovative Journey of Bethany Swencki-Underwood

Introduction

Bethany Swencki-Underwood, an accomplished inventor based in Radnor, PA, has made significant contributions to the field of biotechnology. With a remarkable portfolio of six patents, her work has led to advancements that hold promise for medical applications.

Latest Patents

Among her latest patents is a groundbreaking invention involving isolated polynucleotides encoding CCL17 (CynoCCL17). This patent encompasses polypeptides derived from the expression of these polynucleotides, recombinant cells, and various methods of use. Additionally, she has developed anti-CD147 antibodies, which are immunospecific for human CD147. These antibodies have been shown to block the bioactivity of CD147, particularly in relation to malignant diseases. Their therapeutic potential extends to treating conditions associated with diseases of the eye, lung, and cardiovascular system.

Career Highlights

Bethany's professional journey includes significant roles at Centocor Ortho Biotech Inc. and Janssen Biotech, Inc. Her expertise and innovative mindset have been evident throughout her career, allowing her to navigate complex challenges in the biotechnology sector effectively.

Collaborations

Throughout her career, Bethany has collaborated with several noteworthy professionals, including Michael Naso and Mark Hilary Cunningham. These partnerships have contributed to the success of her inventions, showcasing the importance of teamwork in driving innovation.

Conclusion

Bethany Swencki-Underwood's dedication to research and development has not only led to her own successful inventions but has also positively impacted the medical field. Her innovative spirit and collaborative efforts continue to inspire a new generation of inventors.